Traws amends incentive plan to add 2M shares
Traws Pharma filed an amendment to its 2021 Incentive Compensation Plan, increasing authorized shares by 2 million. The changes require approval at the 2026 Annual Meeting and adjust vesting policies for employee status changes.
View filing at SEC.gov →